Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Seagen Inc (SGEN)  
$228.74 0.00 (0.00%) as of 4:30 Wed 12/13


Download
   
Exchange: Nasdaq National Market
Security Type: Common
Shares Out: 180,310,000
Market Cap: 41.24(B)
Last Volume: 799,597 Avg Vol: 864,930
52 Week Range: $191.51 - $228.9
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Biotechnology

Member Indexes:
    NASDAQ BIOTECHNOLOGY     NASDAQ COMPOSITE
    NASDAQ NNM COMPOSITE

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Seagen is a biotechnology company that develops and commercializes targeted therapies to treat cancer. Co. is commercializing ADCETRIS®, or brentuximab vedotin, for the treatment of certain CD30-expressing lymphomas, PADCEV®, or enfortumab vedotin-ejfv, for the treatment of certain metastatic urothelial cancers, TIVDAK™, or tisotumab vedotin-tftv, for the treatment of certain metastatic cervical cancers, and TUKYSA®, or tucatinib, for treatment of certain metastatic HER2-positive breast cancers. Co. is also developing a pipeline of therapies for solid tumors and blood-related cancers designed to address unmet medical needs and improve treatment outcomes for patients.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 0 0 39,326 449,967
Total Sell Value $0 $0 $8,245,949 $81,866,696
Total People Sold 0 0 7 8
Total Sell Transactions 0 0 18 69
End Date 2024-03-31 2023-12-29 2023-06-30 2022-06-30

   
Records found: 1805
  Page 53 of 73  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Dobmeier Eric Chief Business Officer   •       –      –    2011-04-05 4 AS $16.00 $640,000 D/D (40,000) 25,802     -
   Dobmeier Eric Chief Business Officer   •       –      –    2011-04-05 4 OE $4.45 $219,484 D/D 40,000 33,143     -
   Siegall Clay B President and CEO   •       •      –    2011-03-17 4 AS $14.09 $2,817,280 D/D (200,000) 945,667     -
   Siegall Clay B President and CEO   •       •      –    2011-03-17 4 OE $8.43 $1,686,000 D/D 200,000 1,133,805     -
   Baker Felix Director   –       •       •   2011-02-02 4 B $15.50 $747,054 I/I 48,197 303,449 2.25     -
   Baker Felix Director   –       •       •   2011-02-02 4 B $15.50 $27,152,947 I/I 1,751,803 13,470,692 2.25     -
   Siegall Clay B President and CEO   •       •      –    2011-01-14 4 GD $0.00 $0 D/D 5,833 945,667     -
   Dobmeier Eric Chief Business Officer   •       –      –    2010-12-22 4 OE $5.25 $21,000 D/D 4,000 24,242     -
   Rosenberg Morris EVP, Process Sciences   •       –      –    2010-12-15 4 S $16.22 $405,490 D/D (25,000) 0     -
   Rosenberg Morris EVP, Process Sciences   •       –      –    2010-12-15 4 OE $6.72 $168,000 D/D 25,000 25,000     -
   Gryska David W Director   –       •      –    2010-12-13 5 GD $0.00 $0 D/D 500 25,000     -
   Rosenberg Morris EVP, Process Sciences   •       –      –    2010-12-02 4 S $15.78 $395,295 D/D (25,000) 0     -
   Rosenberg Morris EVP, Process Sciences   •       –      –    2010-12-02 4 OE $6.72 $168,000 D/D 25,000 5,480     -
   Gryska David W Director   –       •      –    2010-11-12 4 OE $5.00 $20,000 D/D 4,000 25,500     -
   Rosenberg Morris EVP, Process Sciences   •       –      –    2010-11-04 4 S $14.70 $367,390 D/D (25,000) 0     -
   Rosenberg Morris EVP, Process Sciences   •       –      –    2010-11-04 4 OE $6.72 $168,000 D/D 25,000 25,000     -
   Reynolds Thomas C Chief Medical Officer   •       –      –    2010-10-11 4 AS $16.95 $423,750 D/D (25,000) 5,719     -
   Reynolds Thomas C Chief Medical Officer   •       –      –    2010-10-11 4 OE $8.24 $206,000 D/D 25,000 30,719     -
   Berger Franklin M Director   –       •      –    2010-10-01 4 OE $8.38 $41,900 D/D 5,000 156,720     -
   Reynolds Thomas C Chief Medical Officer   •       –      –    2010-09-27 4 AS $14.95 $373,750 D/D (25,000) 5,719     -
   Reynolds Thomas C Chief Medical Officer   •       –      –    2010-09-27 4 OE $8.24 $206,000 D/D 25,000 30,719     -
   Siegall Clay B President & CEO   •       •      –    2010-08-31 4 OE $3.00 $144,996 D/D 48,332 951,500     -
   Berger Franklin M Director   –       •      –    2010-08-24 4 OE $7.03 $98,140 D/D 13,000 151,720     -
   Akkaraju Srinivas Director   –       •      –    2010-06-21 4 D $0.00 $0 D/D (50,000) 10,405     -
   Akkaraju Srinivas Director   –       •      –    2010-06-21 4 OE $4.18 $368,300 D/D 50,000 20,405     -
  1805 Records found
  Previous  50  51  52  53  54  55  56  57  58  59  Next   
  Page 53 of 73
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us